EyePoint Pharmaceuticals
EYPT
A$15.12
Share price
-1.79%
Change (1 day)
4.41%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Total assets
Total assets on the balance sheet as of March 2025 : A$0.55 Billion
According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are A$0.55 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | A$0.67 B | 29.05% |
| 2023-12-31 | A$0.52 B | 96.7% |
| 2022-12-31 | A$0.26 B | -27.04% |
| 2021-12-31 | A$0.36 B | 204.56% |
| 2020-12-31 | A$0.11 B | 14.45% |
| 2019-12-31 | A$0.10 B | |
| 2018-06-30 | A$96.81 M | 297.97% |
| 2017-06-30 | A$24.32 M | -42.69% |
| 2016-06-30 | A$42.44 M | 0.91% |
| 2015-06-30 | A$42.06 M | 74.97% |
| 2014-06-30 | A$24.04 M | 35.08% |
| 2013-06-30 | A$17.79 M | -11.49% |
| 2012-06-30 | A$20.1 M | -54.25% |
| 2011-06-30 | A$43.95 M | -13.44% |
| 2010-06-30 | A$50.78 M | 10.72% |
| 2009-06-30 | A$45.86 M | -21.37% |
| 2008-06-30 | A$58.32 M | -51.82% |
| 2007-06-30 | A$0.12 B | -48.79% |
| 2006-06-30 | A$0.23 B | 158.55% |
| 2005-06-30 | A$91.42 M | 125.1% |
| 2004-06-30 | A$40.61 M | 462.71% |
| 2003-06-30 | A$7.21 M | |
| 2001-06-30 | A$9.22 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | A$0.20 B | -62.72% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | A$0.41 M | -99.93% | Bahamas |